These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 21122350)
1. [Effect of ZD6474 on the proliferation of imatinib-resistant K562 cells]. Jia HY; Wu XM; Wang ZY; Deng XY; Lin Z; Feng GL; Huang WL Zhonghua Xue Ye Xue Za Zhi; 2010 Jun; 31(6):371-5. PubMed ID: 21122350 [TBL] [Abstract][Full Text] [Related]
2. ZD6474 inhibits Src kinase leading to apoptosis of imatinib-resistant K562 cells. Jia HY; Wu JX; Zhu XF; Chen JM; Yang SP; Yan HJ; Tan L; Zeng YX; Huang W Leuk Res; 2009 Nov; 33(11):1512-9. PubMed ID: 19394692 [TBL] [Abstract][Full Text] [Related]
3. [The role of Src kinase inhibitor ZD6474 on multi-drug resistant K562/A02 cells]. Jia HY; Li J; Wang ZY; Zhou Q; Wu XM Zhonghua Xue Ye Xue Za Zhi; 2012 Mar; 33(3):220-4. PubMed ID: 22781612 [TBL] [Abstract][Full Text] [Related]
4. [Effect of phenylhexyl isothiocyanate on drug-resistance to imatinib in K562/G01 cell line]. Wu RJ; Huang YQ; Ma XD Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):149-52. PubMed ID: 23611223 [TBL] [Abstract][Full Text] [Related]
5. [Suppression of NAMPT expression enhances the sensitivity of K562 cells to imatinib and its relative mechanism]. Lin PP; Bai XJ; Yue ZX; Yan SF; Li ZW; Gao C; Mei YY; Wang KL; Li WJ; Ding W; Li ZG Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):235-41. PubMed ID: 22541073 [TBL] [Abstract][Full Text] [Related]
6. [Anti-Leukemia Effect and Mechanism of Oridonin on Imatinib-Sensitive and Imatinib-Resistant K562 Cells]. Shan QQ; Guo Y; Gong YP; Lin J; Wang YS Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1378-1383. PubMed ID: 29070111 [TBL] [Abstract][Full Text] [Related]
7. [Apoptosis-inducing effect of tetrandrine and imatinib on K562/G01 cells and its related mechanism]. Shi DX; Ma LM; Lu YJ; Bai B Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):723-8. PubMed ID: 24989284 [TBL] [Abstract][Full Text] [Related]
8. [Effects of HO-1 gene expression on proliferation of imatinib resistant CML cells]. Wang JS; Chai BS; Fang Q; He YY; Chen C; Yang C Zhonghua Xue Ye Xue Za Zhi; 2011 Jun; 32(6):388-91. PubMed ID: 21781496 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of STAT3-interacting protein 1 (STATIP1) promotes STAT3 transcriptional up-regulation and imatinib mesylate resistance in the chronic myeloid leukemia. Mencalha AL; Corrêa S; Salles D; Du Rocher B; Santiago MF; Abdelhay E BMC Cancer; 2014 Nov; 14():866. PubMed ID: 25417721 [TBL] [Abstract][Full Text] [Related]
10. [Effects of STI571 combined with As₂O₃ on proliferation, apoptosis and caspase 3, Bcl-xL expression of K562 cells]. Chen NY; Wang J; Wang XM; Zhang HX; Yan ZY; Wang YM; Zhang S; Yan B Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):882-6. PubMed ID: 20723293 [TBL] [Abstract][Full Text] [Related]
11. [Growth inhibition and differentiation of imatinib-resistant chronic myeloid leukemia cell induced by cell differentiation agent in vitro]. Wang XD; Qiu L; Lu RZ; Chen LJ; Zhan ZM; Han BH; Zhang BL; Ma J Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(48):3399-405. PubMed ID: 18476538 [TBL] [Abstract][Full Text] [Related]
12. [Triptolide inhibits proliferation and induces apoptosis of imatinib resistant K562/G01 cells]. Wen SQ; Ma LM; Lu YJ; Bai B Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1148-52. PubMed ID: 24156423 [TBL] [Abstract][Full Text] [Related]
13. Guggulsterone of Commiphora mukul resin reverses drug resistance in imatinib-resistant leukemic cells by inhibiting cyclooxygenase-2 and P-glycoprotein. Xu HB; Xu LZ; Mao XP; Fu J Phytomedicine; 2014 Jun; 21(7):1004-9. PubMed ID: 24680616 [TBL] [Abstract][Full Text] [Related]
14. Erythropoietin promotes resistance against the Abl tyrosine kinase inhibitor imatinib (STI571) in K562 human leukemia cells. Kirschner KM; Baltensperger K Mol Cancer Res; 2003 Nov; 1(13):970-80. PubMed ID: 14638869 [TBL] [Abstract][Full Text] [Related]
15. The antiproliferation effect of berbamine on k562 resistant cells by inhibiting NF-kappaB pathway. Wei YL; Liang Y; Xu L; Zhao XY Anat Rec (Hoboken); 2009 Jul; 292(7):945-50. PubMed ID: 19548306 [TBL] [Abstract][Full Text] [Related]
16. [Establishment of an imatinib resistant cell line K562/G01 and its characterization]. Qi J; Peng H; Gu ZL; Liang ZQ; Yang CZ Zhonghua Xue Ye Xue Za Zhi; 2004 Jun; 25(6):337-41. PubMed ID: 15308010 [TBL] [Abstract][Full Text] [Related]
17. [Cytotoxic activities of Celecoxib on leukemic cells and the synergistic effects of Celecoxib with Imatinib thereupon]. Li RJ; Gong FJ; Zhang GS Zhonghua Yi Xue Za Zhi; 2006 May; 86(20):1417-20. PubMed ID: 16796927 [TBL] [Abstract][Full Text] [Related]
18. Synergistic interactions between DMAG and mitogen-activated protein kinase kinase 1/2 inhibitors in Bcr/abl+ leukemia cells sensitive and resistant to imatinib mesylate. Nguyen TK; Rahmani M; Gao N; Kramer L; Corbin AS; Druker BJ; Dent P; Grant S Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2239-47. PubMed ID: 16609040 [TBL] [Abstract][Full Text] [Related]
19. The new iodoacetamidobenzofuran derivative TR120 decreases STAT5 expression and induces antitumor effects in imatinib-sensitive and imatinib-resistant BCR-ABL-expressing leukemia cells. Grimaudo S; Meli M; Di Cristina A; Ferro A; Pipitone MR; Romagnoli R; Simoni D; Dieli F; Tolomeo M Anticancer Drugs; 2013 Apr; 24(4):384-93. PubMed ID: 23370613 [TBL] [Abstract][Full Text] [Related]
20. Characteristics of dasatinib- and imatinib-resistant chronic myelogenous leukemia cells. Okabe S; Tauchi T; Ohyashiki K Clin Cancer Res; 2008 Oct; 14(19):6181-6. PubMed ID: 18829496 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]